Premium
Increase in exhaled nitric oxide and protective role of the nitric oxide system in experimental pulmonary embolism
Author(s) -
Nilsson K F,
Gustafsson L E,
Adding L C,
Linnarsson D,
Agvald P
Publication year - 2007
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0707001
Subject(s) - nitric oxide , exhaled nitric oxide , medicine , pulmonary embolism , cardiology , anesthesia , chemistry , lung , lung function
Background and purpose: Pulmonary embolism (PE) represents a real diagnostic challenge. PE is associated with pulmonary hypertension due to pulmonary vascular obstruction and vasoconstriction. We recently reported that pulmonary gas embolism transiently increases exhaled nitric oxide (F E NO), but it is not known whether solid emboli may alter F E NO, and whether an intact endogenous NO synthesis has a beneficial effect in experimental solid pulmonary embolism. Experimental approach: We used anaesthetised and ventilated rabbits in these experiments. To mimic PE, a single intravenous infusion of homogenized autologous skeletal muscle tissue (MPE) was given to rabbits with intact NO production (MPE of 60, 15, or 7.5 mg kg −1 ; group 1) and to another group (group 2) with inhibited NO synthesis ( L ‐NAME 30 mg kg −1 ; MPE of 7.5, 15 or 30 mg kg −1 ). Key results: In group 1, after MPE, F E NO increased rapidly and dose‐dependently and F E NO was still significantly elevated after 60 min with the two highest emboli doses. All these animals survived more than 60 min after embolization. In group 2, MPE of 7.5, 15 and 30 mg kg −1 , in combination with NO synthesis inhibition, resulted in 67%, 50% and 25% survival at 60 min respectively, representing a statistically significant decrease in survival. Cardiovascular and blood‐gas changes after MPE were intensified by pre‐treatment with NO synthesis inhibitor. Conclusions and implications: We conclude that solid PE causes a sustained, dose‐dependent increase in F E NO, giving F E NO a diagnostic potential in PE. Furthermore, intact NO production appears critical for tolerance to acute PE. British Journal of Pharmacology (2007) 150 , 494–501. doi: 10.1038/sj.bjp.0707001